Patents by Inventor Rolf Stefan Brickl

Rolf Stefan Brickl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of selected CGRP-antagonists in combination with other antimigraine drugs for the treatment of migraine
    Publication number: 20060142273
    Abstract: The present invention relates to a process for the treatment or prevention of indications which are selected from among the group comprising headaches, migraine and cluster headaches, this process comprising the joint administration of a therapeutically effective amount of a selected CGRP antagonist (A), a physiologically acceptable salt thereof or a hydrate of the salt and a therapeutically effective amount of a second or third active anti-migraine medicament (B), particularly sumatriptan, zolmitriptan or dihydroergotamine or a physiologically acceptable salt thereof, and to the corresponding pharmaceutical compositions and the preparation thereof.
    Type: Application
    Filed: December 16, 2005
    Publication date: June 29, 2006
    Applicant: Boehringer Ingelheim International Gmbh
    Inventors: Klaus RUDOLF, Henri DOODS, Stephan MUELLER, Annette ZAMPONI, Philipp LUSTENBERGER, Kirsten ARNDT, Gerhard SCHAENZLE, Dirk STENKAMP, Rolf-Stefan Brickl
  • Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof
    Publication number: 20060051419
    Abstract: An extended release pellet comprising an active ingredient selected from pramipexole and the pharmaceutically acceptable salts thereof, and at least one release-modifying excipient.
    Type: Application
    Filed: August 12, 2005
    Publication date: March 9, 2006
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Thomas Friedl, Rolf-Stefan Brickl
  • Administration form for the oral application of poorly soluble drugs
    Publication number: 20050095293
    Abstract: The invention relates to a new formulation for oral administration of active substances with pH-dependent solubility characteristics and the pharmacologically acceptable salts thereof, which improves the bioavailability of the active substance.
    Type: Application
    Filed: September 3, 2004
    Publication date: May 5, 2005
    Applicant: Boehringer Ingelheim Pharma GmbH Co. KG
    Inventors: Ulrich Brauns, Rolf-Stefan Brickl
  • Administration form for the oral application of poorly soluble acidic and amphorteric drugs
    Publication number: 20050053669
    Abstract: The invention relates to a new formulation for oral administration of active substances with pH-dependent solubility characteristics and the pharmacologically acceptable salts thereof, which improves the bioavailability of the active substance.
    Type: Application
    Filed: August 24, 2004
    Publication date: March 10, 2005
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Thomas Friedl, Rolf-Stefan Brickl, Ulrich Brauns
  • Dermatological compositions containing an acylamino-carboxylic acid or an alkyl ester thereof
    Patent number: 4016287
    Abstract: Topical dermatological compositions containing an acylamino-carboxylic acid compound of the formula ##STR1## wherein R.sub.1 is hydrogen, alkyl of 1 to 3 carbon atoms, trifluoromethyl, phenyl, halo-phenyl, nitro-phenyl or biphenylyl,R.sub.2 is hydrogen or alkyl of 1 to 3 carbon atoms,R.sub.3 is hydrogen, alkyl of 1 to 6 carbon atoms, methylthio-(alkyl of 1 to 6 carbon atoms) or benzyl,R.sub.4 is alkyl of 10 to 22 carbon atoms,n is 0, 1 or 2,R.sub.5 is alkyl of 8 to 22 carbon atoms, phenyl or biphenylyl, andR.sub.6 is hydrogen or alkyl of 1 to 3 carbon atoms; the compositions are useful for the care of the skin.
    Type: Grant
    Filed: July 17, 1975
    Date of Patent: April 5, 1977
    Assignee: Boehringer Ingelheim GmbH
    Inventors: Hans Eberhardt, Rolf Stefan Brickl
  • Aminocarboxylic acid higher alkylamides
    Patent number: 3948943
    Abstract: Compounds of the formula ##EQU1## wherein R.sub.1 is lower alkyl or aryl,R.sub.2 is hydrogen or, together with R.sub.1, ethylene, andR.sub.3 is straight or branched alkyl of 8 to 22 carbon atoms;The compounds have useful therapeutic, dermatological and cosmetic properties.
    Type: Grant
    Filed: April 29, 1974
    Date of Patent: April 6, 1976
    Assignee: Boehringer Ingelheim GmbH
    Inventors: Hans Eberhardt, Rolf Stefan Brickl